METTL3 and m6A were upregulated in human osteosarcoma (46), gastric cancer (23, 47, 48), melanoma (49), ovarian carcinoma (50), and hepatocellular carcinoma (51). This evidence concerns the gene METTL3 and ovarian carcinoma.